| Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria RJ Kelly, B Höchsmann, J Szer, A Kulasekararaj, S De Guibert, A Röth, ... New England Journal of Medicine 373 (11), 1032-1039, 2015 | 244 | 2015 |
| Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The Ninth Special … L Connelly‐Smith, CR Alquist, NA Aqui, JC Hofmann, R Klingel, ... Journal of clinical apheresis 38 (2), 77-278, 2023 | 161 | 2023 |
| Thrombotic microangiopathies: a general approach to diagnosis and management DM Arnold, CJ Patriquin, I Nazy Cmaj 189 (4), E153-E159, 2017 | 152 | 2017 |
| Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura CJ Patriquin, MR Thomas, T Dutt, S McGuckin, PA Blombery, T Cranfield, ... British journal of haematology 173 (5), 779-785, 2016 | 87 | 2016 |
| Therapeutic plasma exchange in vaccine-induced immune thrombotic thrombocytopenia CJ Patriquin, V Laroche, R Selby, J Pendergrast, D Barth, B Côté, ... New England Journal of Medicine 385 (9), 857-859, 2021 | 85 | 2021 |
| Eculizumab and beyond: the past, present, and future of complement therapeutics CJ Patriquin, KHM Kuo Transfusion medicine reviews 33 (4), 256-265, 2019 | 66 | 2019 |
| How we treat paroxysmal nocturnal hemoglobinuria: a consensus statement of the Canadian PNH Network and review of the national registry CJ Patriquin, T Kiss, S Caplan, I Chin‐Yee, K Grewal, J Grossman, ... European Journal of Haematology 102 (1), 36-52, 2019 | 61 | 2019 |
| Treatment of warfarin-associated coagulopathy with vitamin K C Patriquin, M Crowther Expert review of hematology 4 (6), 657-667, 2011 | 45 | 2011 |
| Making the correct diagnosis in thrombotic microangiopathy: a narrative review PA McFarlane, M Bitzan, C Broome, D Baran, J Garland, LP Girard, ... Canadian Journal of Kidney Health and Disease 8, 20543581211008707, 2021 | 37 | 2021 |
| Renal thrombotic microangiopathy: a review DS Genest, CJ Patriquin, C Licht, R John, HN Reich American Journal of Kidney Diseases 81 (5), 591-605, 2023 | 36 | 2023 |
| Increased eculizumab requirements during pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: case report and review of the literature C Patriquin, B Leber Clinical case reports 3 (2), 88, 2015 | 25 | 2015 |
| Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double … JW Lee, M Griffin, JS Kim, LWL Lee, C Piatek, J Nishimura, CC Infante, ... The Lancet Haematology 10 (12), e955-e965, 2023 | 20 | 2023 |
| Long-term outcomes of sensitized lung transplant recipients after peri-operative desensitization M Aversa, T Martinu, C Patriquin, M Cypel, D Barth, R Ghany, J Ma, ... American Journal of Transplantation 21 (10), 3444-3448, 2021 | 18 | 2021 |
| How we treat thrombotic thrombocytopenic purpura: results of a Canadian TTP practice survey CJ Patriquin, WF Clark, K Pavenski, DM Arnold, G Rock, SR Foley, ... Journal of clinical apheresis 32 (4), 246-256, 2017 | 18 | 2017 |
| The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria AG Kulasekararaj, RA Brodsky, J Nishimura, CJ Patriquin, ... Therapeutic Advances in Hematology 13, 20406207221091046, 2022 | 14 | 2022 |
| Simple diagnosis and treatment algorithm for adult thrombotic microangiopathy WF Clark, C Patriquin, C Licht, SH Huang, G Rock Transfusion and Apheresis Science 56 (1), 50-51, 2017 | 11 | 2017 |
| RA101495, a subcutaneously-administered peptide inhibitor of complement component C5, for the treatment of paroxysmal nocturnal hemoglobinuria: phase 2 results A Hill, H Schrezenmeier, P Hillmen, J Szer, H Pullon, R Spearing HemaSphere. 2, 122, 2018 | 10 | 2018 |
| A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease LE Rotin, A Viswabandya, R Kumar, CJ Patriquin, KHM Kuo Hematology 28 (1), 2163357, 2023 | 8 | 2023 |
| Danicopan as add-on therapy to ravulizumab or eculizumab versus placebo in patients with paroxysmal nocturnal hemoglobinuria and clinically significant extravascular hemolysis … A Kulasekararaj, M Griffin, CI Piatek, J Shammo, JI Nishimura, ... Blood 142, 576, 2023 | 8 | 2023 |
| O, wind, if winter comes … will symptoms be far behind? Exploring the seasonality (or lack thereof) and management of cold agglutinin disease CJ Patriquin, K Pavenski Transfusion 62 (1), 2-10, 2022 | 8 | 2022 |
